Attached files
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the inclusion in this registration statement of Primus
Therapeutics, Inc. on Form S-1 of our report dated February 9, 2011 on our audit
of the balance sheet of Primus Therapeutics Inc. as of December 31, 2010, and
the related statements of operations, stockholders deficiency and
cash flows for the period from April 21, 2010 (Inception) to December 31, 2010,
which report includes an explanatory paragraph relating to Primus Therapeutics,
Inc.s ability to continue as a going concern. We also consent to the reference
to our firm under the caption Experts.
/s/ J.H. Cohn LLP
Princeton, New Jersey
February 9, 2011